Cambridge Investment Research Advisors
MORF

Cambridge Investment Research Advisors’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-39,996
Closed -$1.5M – 3316
2023
Q1 		$1.5M Buy
+39,996
New +$1.47M 0.01% 1309

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Cambridge Investment Research Advisors's MORF Position: Q2 2023 in Review

Cambridge Investment Research Advisors sold out of Morphic Holding, Inc. Common Stock (MORF) in Q2 2023, closing a stake of 39,996 shares — an estimated $1.5M sold.

Cambridge Investment Research Advisors first reported a position in MORF in Q1 2023 and held it in 1 quarter. The position peaked at $1.5M in Q1 2023. 152 funds tracked by Wall St. Rank hold MORF as of Q2 2023.

  • Cambridge Investment Research Advisors reported no remaining Morphic Holding, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 39,996 Morphic Holding, Inc. Common Stock shares in Q2 2023, an estimated $1.5M.
  • Cambridge Investment Research Advisors first reported a position in Morphic Holding, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Morphic Holding, Inc. Common Stock position peaked at $1.5M in Q1 2023.
  • 152 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q2 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.